![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.onclive.com/view/nox-a12-plus-bevacizumab-and-radiotherapy-shows-sustained-survival-in-glioblastoma
https://www.businesswire.com/news/home/20210510005558/en/NOXXON-Announces-Data-Safety-Monitoring-Board-Validates-NOX-A12-Highest-Dose-in-Phase-12-Brain-Cancer-Trial